Novo bets big on diabetes meds

Share this article:

Novo Nordisk is investing $3.65 billion in needle-free diabetes treatments. Reuters reports that the drug maker is looking to develop pills that can replace injected insulins, and tells the news service it has dedicated 500 employees to developing six candidates.

The company projects that it could have the new medication market-ready in 10 years.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Miss Idaho shows off diabetes pump

NPR reports that the move has made Sierra Sandison a type 1 diabetes hero and that users have given the Facebook photo over 4,000 "likes."

Roche is hungry, not starving for M&A

CEO Severin Schwan tells Reuters that the Swiss firm will be looking for small acquisitions and partnerships.

AbbVie nabs Shire for $54B

AbbVie, in the latest example of a US drugmaker seeking to lower its tax rate, said today that it's buying Dublin-based Shire for $54 billion.